ARCHIVES

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Trials Listed

April 28, 2006

NCI Proposed 1980 Budget Increases R01 Grants By $50 Million Over ’79; Total – $1.055 Billion

June 9, 1978

Anti-Nausea Drug Successful In Phase III Trial in Highly Emetogenic Chemotherapy

May 30, 2014

Cancer survivors number 9.8 million in U.S., CDC says.

June 25, 2004

Reimbursement Of Some Anticancer Drugs Expected To Drop Sharply Under HHS Policy.

June 30, 2000

Gleevec Better Than Interferon For Newly Diagnosed CML

May 31, 2002